PCIM&H under Ministry of Ayush Launches 5-Day Training Programme to Strengthen ASU&H Drug Regulation and Quality Standards
PCIM&H under Ministry of Ayush Launches 5-Day Training Programme to Strengthen ASU&H Drug Regulation and Quality Standards
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) today inaugurated a five-day Capacity Building Training Program for stakeholders engaged in the regulatory, academic, quality control, and manufacturing domains of Ayurveda, Siddha, Unani, and Homoeopathy (ASU&H) medicines. The specialized program, scheduled from November 24 to November 28, 2025, is designed to strengthen the knowledge and skills of drug regulators, enforcement authorities, quality control personnel, technical experts, government analysts, researchers, and scientists dedicated to ASU&H drug development and quality assurance.
Dr. Preetha Kizhakkutil, Advisor (Homoeopathy), Ministry of Ayush, graced the inaugural session as the Chief Guest. In her address, she commended PCIM&H for its pivotal role in developing quality standards for ASU&H drugs, particularly through the adoption of advanced instruments and modern analytical techniques.
Prof. (Dr.) Kashinath Samagandi, Director, Morarji Desai National Institute of Yoga and Naturopathy, Ministry of Ayush, highlighted the growing global acceptance of pharmacopoeias and formularies developed by PCIM&H. He emphasized that the increasing international interest in ASU&H systems reflects India’s leadership in traditional medicine.
Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the Commission’s mandate, ongoing initiatives, and its role in standard-setting and quality control of Indian systems of medicine. The event was also attended by Dr. N. Murugesan, Former Director, Central Drug Testing Laboratory (CDTL), Chennai, as Special Guest.
Over the next five days, participants will receive expert-led lectures, exposure visits, and hands-on sessions covering a wide spectrum of subjects, including NABL Accreditation and Quality Management Systems (QMS); Good Manufacturing Practices (GMP); Pharmacognostic, Physico-chemical, Phytochemical, Microbiological and Pharmacological Evaluation of ASU&H drugs; Standardization and Quality Control of Herbal Drugs; Regulatory and Pharmacopoeial Standards; and Shelf-life Studies.
The programme also includes practical training in PCIM&H laboratories and field visits to ASU&H drug manufacturing units such as Dr. Willmar Schwabe India Pvt. Ltd., Noida and Hamdard Laboratories India, Ghaziabad. These components aim to enhance technical proficiency by exposing participants to the latest technologies and best practices in the sector.
A total of 35 participants from across the country are attending the training, representing State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, Ayush-accredited Drug Testing Laboratories, National Institutes and Research Centres including the National Institute of Siddha (Chennai), National Institute of Ayurveda (Jaipur), Siddha Central Research Institute (Chennai), National Research Institute of Unani Medicine for Skin Disorders (Hyderabad), Dr. D.P. Rastogi Central Research Institute for Homoeopathy (Noida), Regional Research Institute of Unani Medicine (Srinagar), and several Ayush colleges and hospitals from Uttar Pradesh, Telangana, Assam, Kanpur and other regions.
This Capacity Building Training Programme by PCIM&H marks a significant step toward strengthening the regulatory ecosystem of ASU&H drugs in India. By equipping professionals with enhanced knowledge and practical skills, the initiative supports the nation’s commitment to maintaining high quality standards and advancing traditional systems of medicine at the global level.
